Zhao, Yiming

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Chu, T., Zhong, R., Zhong, H., Zhang, B., Zhang, W., Shi, C., Qian, J., Zhang, Y., Chang, Q., Zhang, X., et al. (2021) · Journal of Thoracic Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 227

An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Wu, Y., Zhao, Y., Huan, L., Zhao, J., Zhou, Y., Xu, L., Hu, Z., Liu, Y., Chen, Z., Wang, L., et al. (2020) · Cancer Research

Cancer-related molecular mechanisms researchChromosomal and Genetic Variations

Cited by 72

Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature

Shen, M., Li, S., Zhao, Y., Liu, Y., Liu, Z., Huan, L., Qiao, Y., Wang, L., Han, L., Chen, Z., et al. (2022) · Cell Death & Disease

Cancer Cells and MetastasisHepatocellular Carcinoma Treatment and Prognosis

Cited by 25